Cinnarizine/Dimenhydrinate

桂利嗪/茶苯海明

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCinnarizine/Dimenhydrinate
Drug Alias NameCinnarizine-Dimenhydrinate桂利嗪茶苯海明Cinnarizine•Dimenhydrinate桂利嗪-茶苯海明Dimenhydrinate/Cinnarizine +[11
ClassificationSmall molecules
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsVertigo
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHennig Arzneimittel
China Registration ClassN/A

Develop Information

Active CompaniesHennig Arzneimittel
Inactive CompaniesN/A
Active IndicationsVertigo
Inactive IndicationsN/A

Other Information

ATC CodeN07CA52
Related LinksN/A